Resveratrol Treatment Is Associated with Lipid Regulation and Inhibition of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) in Rabbits Fed a High-Fat Diet

Table 1

Biochemical analysis of rabbits from NDG (n = 8), FDG (n = 8), and RFG (n = 8) analyzed before the beginning of the fat diet (baseline).

		NDG (n = 8)	FDG (n = 8)	RFG (n = 8)	F	value
Weight (kg)		0.96 ± 0.05	0.99 ± 0.08	1.01 ± 0.08	0.903	0.420
ALT		43.20 ± 9.65	41.22 ± 8.83	44.76 ± 12.80	0.226	0.800
AST		36.38 ± 8.61	33.73 ± 5.91	34.88 ± 4.98	0.317	0.732
CREA		67.94 ± 8.39	64.72 ± 6.27	65.75 ± 9.69	0.318	0.731
TG		0.63 ± 0.20	0.50 ± 0.16	0.48 ± 0.07	2.230	0.132
TC		1.94 ± 0.21	1.88 ± 0.28	1.99 ± 0.43	0.240	0.789
HDL-C		0.93 ± 0.19	0.94 ± 0.25	0.93 ± 0.17	0.006	0.994
LDL-C		0.84 ± 0.22	0.95 ± 0.12	0.80 ± 0.27	1.053	0.367
Lp-PLA2^#		461.50 ± 89.57	525.48 ± 32.50	494.88 ± 32.56	2.424	0.113

^#The test result of homogeneity of variance was , and Dunnett’s T method was used for multiple comparison of value correction, while the Bonferroni method was used for the other indicators. NDG, normal diet group; FDG, fat diet group; RFG, fat diet with resveratrol; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CREA, creatinine; TG, triglycerides; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Lp-PLA2, lipoprotein-associated phospholipase A2.